These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 34016131
1. Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head. Liu M, Zhao G, Wei BF. J Orthop Surg Res; 2021 May 20; 16(1):325. PubMed ID: 34016131 [Abstract] [Full Text] [Related]
2. Serum α-melanocyte-stimulating hormone may act as a protective biomarker for non-traumatic osteonecrosis of the femoral head. Mao Z, Liu G, Chen JJ, Liu D, Xu MP, Zhao C, Yang HT, Yue YB. Ann Clin Biochem; 2018 Jul 20; 55(4):453-460. PubMed ID: 28990818 [Abstract] [Full Text] [Related]
3. Decreased serum CXCL12/SDF-1 concentrations may reflect disease severity of non-traumatic osteonecrosis of femoral head. Zheng SW, Sun CH, Wen ZJ, Liu WL, Li X, Chen TY, Zou YC, Zhong HB, Shi ZJ. Clin Chim Acta; 2022 Apr 01; 529():87-95. PubMed ID: 35183527 [Abstract] [Full Text] [Related]
4. Reduced serum and local LncRNA MALAT1 expressions are linked with disease severity in patients with non-traumatic osteonecrosis of the femoral head. Jin Y, Zhu HX, Wei BF. Technol Health Care; 2021 Apr 01; 29(3):479-488. PubMed ID: 32716338 [Abstract] [Full Text] [Related]
5. Plasma and local expressions of CircRNA CDR1as are linked with disease severity in patients with non-traumatic osteonecrosis of femoral head. Jiang B, Zhu SH, Zeng JY, Mao Z. J Orthop Surg Res; 2020 Dec 09; 15(1):592. PubMed ID: 33298118 [Abstract] [Full Text] [Related]
6. Attenuated serum adiponectin levels are associated with disease severity in patients with non-traumatic osteonecrosis of the femoral head. Yue YB, Liu X, Wei BF. J Pain Res; 2017 Dec 09; 10():2387-2393. PubMed ID: 29042814 [Abstract] [Full Text] [Related]
7. Decreased serum MMP-9 levels in patients with nontraumatic osteonecrosis of the femoral head. Li G, Ji F, Guo W, Wei B. BMC Musculoskelet Disord; 2023 Mar 29; 24(1):240. PubMed ID: 36991363 [Abstract] [Full Text] [Related]
8. Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head. Zhao YH, Zhu WX, Ye QH, Zhang P, Wei BF. J Orthop Surg Res; 2024 Mar 01; 19(1):162. PubMed ID: 38429811 [Abstract] [Full Text] [Related]
9. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study. Wang W, Wang ZP, Huang CY, Chen YD, Yao WF, Shi BM. Genet Test Mol Biomarkers; 2019 Jul 01; 23(7):480-486. PubMed ID: 31157986 [Abstract] [Full Text] [Related]
10. [Predictive effect of femoral neck strength composite indexes on femoral head collapse in non-traumatic osteonecrosis of femoral head]. Lin T, Yang P, Cai K, Li Z, Pang F, Zhang Q, He W, Wei Q. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Aug 15; 35(8):967-972. PubMed ID: 34387423 [Abstract] [Full Text] [Related]
11. [OBSERVATION OF EFFECTIVENESS OF HIP RESURFACING ARTHROPLASTY IN TREATMENT OF OSTEONECROSIS OF FEMORAL HEAD IN YOUNG AND MIDDLE-AGED PATIENTS]. Yu Y, Yi C, Ma J, Wang Q. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Feb 15; 30(2):133-7. PubMed ID: 27276801 [Abstract] [Full Text] [Related]
12. Serum nicotinamide phosphoribosyltransferase as a novel biomarker for non-traumatic osteonecrosis of the femoral head. Wang S, Zhan H, Xu L, Zhao B. J Orthop Surg Res; 2022 Nov 28; 17(1):514. PubMed ID: 36443772 [Abstract] [Full Text] [Related]
13. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study. Mao Q, Jin H, Liao F, Xiao L, Chen D, Tong P. Bone; 2013 Dec 28; 57(2):509-16. PubMed ID: 23994171 [Abstract] [Full Text] [Related]
14. Lipid metabolism analysis for peripheral blood in patients with alcohol-induced and steroid-induced osteonecrosis of the femoral head. Yan Y, Yu Y, Liu J, Zhao H, Wang J. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul 28; 47(7):872-880. PubMed ID: 36039583 [Abstract] [Full Text] [Related]
15. Long-term outcome of vascularized iliac bone grafting for osteonecrosis of femoral head: A retrospective study with 17-year follow-up. Lau HW, Wong KC, Ho K, Chung KY, Chiu WK, Kumta SM. J Orthop Surg (Hong Kong); 2021 Jul 28; 29(1):2309499021996842. PubMed ID: 33641533 [Abstract] [Full Text] [Related]
16. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. Massari L, Fini M, Cadossi R, Setti S, Traina GC. J Bone Joint Surg Am; 2006 Nov 28; 88 Suppl 3():56-60. PubMed ID: 17079368 [Abstract] [Full Text] [Related]
17. Mid-term outcomes of arthroscopic-assisted Core decompression of Precollapse osteonecrosis of femoral head-minimum of 5 year follow-up. Nazal MR, Parsa A, Martin SD. BMC Musculoskelet Disord; 2019 Oct 15; 20(1):448. PubMed ID: 31615502 [Abstract] [Full Text] [Related]
18. S100 Calcium Binding Protein A9 Represses Angiogenic Activity and Aggravates Osteonecrosis of the Femoral Head. Wu RW, Lian WS, Kuo CW, Chen YS, Ko JY, Wang FS. Int J Mol Sci; 2019 Nov 18; 20(22):. PubMed ID: 31752076 [Abstract] [Full Text] [Related]
19. Plasma ghrelin and von Willebrand Factor levels in patients with non-traumatic osteonecrosis of the femoral head. Li C, Shen L, Yang Y, Shuai B, Xu X, Ma C. Hip Int; 2015 Nov 18; 25(1):76-81. PubMed ID: 25362875 [Abstract] [Full Text] [Related]
20. Percutaneous autologous impaction bone graft for advanced femoral head osteonecrosis: a retrospective observational study of unsatisfactory short-term outcomes. Kuroda Y, Nankaku M, Okuzu Y, Kawai T, Goto K, Matsuda S. J Orthop Surg Res; 2021 Feb 17; 16(1):141. PubMed ID: 33596957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]